Rare endocrine tumours of the GI tract

Best Practice and Research: Clinical Gastroenterology

Volumn 19, Issue 5 SPEC. ISS., 2005, Pages 807-817

  Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Glucagonoma; Somatostatinoma; VIPoma

Indexed keywords

ANTICOAGULANT AGENT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR; KETOCONAZOLE; LONG ACTING DRUG; NEUROTENSIN; POTASSIUM ION; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ACROMEGALY; ADRENALECTOMY; ARTICLE; CHOLECYSTECTOMY; CLINICAL FEATURE; CUSHING DISEASE; DEEP VEIN THROMBOSIS; ECTOPIC CORTICOTROPIN PRODUCTION; GASTRINOMA; GASTROINTESTINAL TUMOR; GLUCAGONOMA; HORMONAL REGULATION; HUMAN; INSULINOMA; MALIGNANT NEOPLASTIC DISEASE; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PANCREATICODUODENECTOMY; PREOPERATIVE CARE; RARE DISEASE; REHYDRATION; SOMATOSTATINOMA; SYNDROME; TOTAL PARENTERAL NUTRITION; TUMOR LOCALIZATION; VENA CAVA FILTER; VIPOMA;

EID: 27744524874     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2005.05.004     Document Type: Review

References (43)

1. K. Oberg & B. Erikson Medical treatment of neuroendocrine gut and pancreatic tumors Acta Oncol 28 1989 425
2. B. Wiedenmann R.T. Jensen M. Mignon et al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop World J Surg 22 3 1998 309-318
3. G.M. Doherty & J.A. Norton The diagnosis and management of metastatic malignant neuroendocrine tumors Probl Gen Surg 11 1994 120-141
4. R.L. Roczen & D.K. Andersen Gastrointestinal hormones in disease Probl Gen Surg 11 1 1994 21-52
5. J.V. Verner & A.B. Morrison Endocrine pancreatic islet disease with diarrhea: Report of a case due to diffuse hyperplasia of no beta islet tissue with a review of 54 additional cases Arch Intern Med 1974 1974 133-492
6. J.V. Verner & A.B. Morrison Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia Am J Med 29 1958 529
7. I.N. Marks S. Bank & J.H. Louw Islet cell tumor of the pancreas with reversible watery diarrhea and achlorhydria Gastroenterology 52 1967 670-695
8. S.L. Smith S.A. Branton A.J. Avino et al. Vasoactive intestinal polypeptide secreting islet cell tumors: A 15-year experience and review of the literature Surgery 124 6 1998 1050-1055
9. M. Holm-Bentzen A. Schulta J. Fahrenkrug et al. Effect of VIP on gastric acid secretion in man Hepatogastroenterology 27 supplement 1980 126-130
10. T.M. O'Dorisio H.S. Mehkjian & T.S. Gaginella Medical therapy of VIPomas Endocrinol Metab Clin North Am 18 1989 545-550
11. S.R. Bloom R.G. Long M.G. Bryant et al. Clinical, biochemical and pathological studies on 62 VIPomas Gastroenterology 78 1980 1143
12. P.N. Maton T.M. O'Dorisio B.A. Howe et al. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera N Engl J Med 312 1985 17-21
13. D.M. Nagorney S.R. Bloom J.M. Polak & L.M. Blumgart Resolution of recurrent Verner-Morrison syndrome by resection of metastatic VIPoma Surgery 93 1983 348-353
14. D.M. Nagorney & F.G. Que Cytoreductive hepatic surgery for metastatic gastrointestinal neuroendocrine tumors In M. Mignon & R.T. Jensen (eds.) Endocrine Tumors of the Pancreas: Recent Advances in Research and Management 0 edn 1995 S. Karger Basel, Switzerland 416-430
15. C.D. Joyce & R.A. Prinz The glucagonoma syndrome Probl Gen Surg 11 1 1994 83-98
16. J.A. Norton C.R. Kahn R. Schieberger et al. Amino acid deficiency and skin rash associated with glucagonoma Ann Intern Med 91 1979 213-215
17. C.N. Mallinson S.R. Bloom A.P. Warin et al. A glucagonoma syndrome Lancet 2 1974 1
18. M.A. Chastain The glucagonoma syndrome: A review of its features and discussion of new perspectives Am J Med Sci 321 5 2001 306-320
19. G. Akerstrom P. Hellman O. Hessman & L. Osmak Surgical treatment of endocrine pancreatic tumours Neuroendocrinology 80 supplement 1 2004 62-66
20. M. Bernstein F. Jahoor C.M. Townsend Jr & S. Klein Amino acid, glucose, and lipid kinetics after palliative resection in a patient with glucagonoma syndrome Metabolism 50 6 2001 720-722
21. I. Madeira B. Terris M. Voss et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area Gut 43 3 1998 422-427
22. E.C. Ellison & J.A. Johnson Gastrointestinal peptides: Basic physiology and clinical significance Probl Gen Surg 11 1 1994 1-20
23. P.O. Ganda G.C. Weir J.S. Soeldner et al. Somatostatinoma: A somatostatin-containing tumor of the endocrine pancreas N Engl J Med 296 1977 963
24. L.I. Larsson M.A. Hirsch J. Holst et al. Pancreatic somatostatinoma clinical features and physiologic implications Lancet 1 1977 666
25. G.J. Krejs L. Orci M. Conlon et al. Somatostatinoma syndrome (biochemical, morphological, and clinical features) N Engl J Med 301 1979 285-290
26. T.R. Kelly Somatostatinoma Probl Gen Surg 11 1 1994 99-119
27. D.C. Metz Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours Italian J Gastroenterol Hepatol 31 supplement 2 1999 S153-S159
28. C. Cappelli B. Agosti M. Braga et al. Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature Minerva Endocrinol 29 1 2004 19-24
29. M.A. Zeiger H.I. Pass J.D. Doppman et al. Surgical strategy in the management of non-small cell ectopic adrenocorticotropic hormone syndrome Surgery 112 1992 994-1001
30. P.N. Maton J.D. Gardner & R.T. Jensen Cushing's syndrome in patients with the Zollinger-Ellison syndrome N Engl J Med 315 1986 1-5
31. T. Sano S.L. Asa & K. Kovacs Growth hormone releasing-producing tumors: Clinical, biochemical and morphological manifestations Endocr Rev 9 1988 357-373
32. T. Sano R. Yamasaki H. Saito et al. Growth hormone-releasing hormone (GHRH) secreting pancreatic tumor in a patient with multiple endocrine neoplasia type 1 Surg Pathol 11 1987 810
33. P. Ruszniewski & D. O'Toole Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors Neuroendocrinology 80 supplement 1 2004 74-78
34. J. Tepel S. Hinz H.J. Klomp et al. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies Eur J Surg Oncol 30 5 2004 551-555
35. E. Berber N.L. Herceg K.J. Casto & A.E. Siperstein Laparoscopic radiofrequency ablation of hepatic tumors: Prospective clinical evaluation of ablation size comparing two treatment algorithms Surg Endosc 18 3 2004 390-396
36. R. Sutcliffe D. Maguire J. Ramage et al. Management of neuroendocrine liver metastases Am J Surg 187 1 2004 39-46
37. A.R. Henn E.A. Levine W. McNulty & R.J. Zagoria Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.[see comment] Am J Roentgenol 181 4 2003 1005-1010
38. S.A. Gulec T.S. Mountcastle D. Frey et al. Cytoreductive surgery in patients with advanced-stage carcinoid tumors Am Surg 68 8 2002 667-671
39. E. Berber N. Flesher & A.E. Siperstein Laparoscopic radiofrequency ablation of neuroendocrine liver metastases World J Surg 26 8 2002 985-990
40. M.H. Chung J. Pisegna M. Spirt et al. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: A paradigm for intractable neuroendocrine tumors metastatic to the liver Surgery 130 6 2001 954-962
41. S.V. Welin E.T. Janson A. Sundin et al. High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours Eur J Endocrinol 151 1 2004 107-112
42. K. Oberg L. Kvols M. Caplin et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system Ann Oncol 15 6 2004 966-973
43. E.T. Janson & K. Oberg Neuroendocrine tumors - somatostatin receptor expression and somatostatin analog treatment Cancer Chemother Biol Response Modif 21 2003 535-546